{
  "DOI": "10.1007/s10689-012-9556-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-012-9556-0",
  "alternative-id": [
    "9556"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Penkert",
      "given": "Judith",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Schlegelberger",
      "given": "Brigitte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Steinemann",
      "given": "Doris",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gadzicki",
      "given": "Dorothea",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        8,
        3
      ]
    ],
    "date-time": "2012-08-03T07:50:19Z",
    "timestamp": 1343980219000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T17:46:08Z",
    "timestamp": 1559238368000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        1
      ]
    ],
    "date-time": "2023-09-01T05:09:41Z",
    "timestamp": 1693544981785
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2012,
        8,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2012,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            8,
            4
          ]
        ],
        "date-time": "2012-08-04T00:00:00Z",
        "timestamp": 1344038400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-012-9556-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-012-9556-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-012-9556-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "601-606",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2012,
        8,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        8,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/ncb2038",
      "author": "J Drost",
      "doi-asserted-by": "crossref",
      "first-page": "380",
      "journal-title": "Nature Cell Biol",
      "key": "9556_CR1",
      "unstructured": "Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R, Del Sal G (2010) BRD7 is a candidate tumour suppressor gene required for p53 function. Nature Cell Biol 12:380–389",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-2089",
      "author": "MT Harte",
      "doi-asserted-by": "crossref",
      "first-page": "2538",
      "journal-title": "Cancer Res",
      "key": "9556_CR2",
      "unstructured": "Harte MT, O’Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, Mullan PB, Harkin DP (2010) BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res 70:2538–2547",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature08822",
      "author": "R Beroukhim",
      "doi-asserted-by": "crossref",
      "first-page": "899",
      "journal-title": "Nature",
      "key": "9556_CR3",
      "unstructured": "Beroukhim R, Mermel CH, Porter D et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899–905",
      "volume": "463",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.1009559107",
      "author": "AE Burrows",
      "doi-asserted-by": "crossref",
      "first-page": "14280",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9556_CR4",
      "unstructured": "Burrows AE, Smogorzewska A, Elledge SJ (2010) Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci USA 107:14280–14285",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2407-8-253",
      "author": "H Liu",
      "doi-asserted-by": "crossref",
      "first-page": "253",
      "journal-title": "BMC Cancer",
      "key": "9556_CR5",
      "unstructured": "Liu H, Zhang L, Niu Z, Zhou M, Peng C, Li X, Deng T, Shi L, Tan Y, Li G (2008) Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer 8:253",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1126/science.7545954",
      "author": "Y Miki",
      "doi-asserted-by": "crossref",
      "first-page": "66",
      "journal-title": "Science",
      "key": "9556_CR6",
      "unstructured": "Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.7326/0003-4819-71-4-747",
      "author": "FP Li",
      "doi-asserted-by": "crossref",
      "first-page": "747",
      "journal-title": "Ann Intern Med",
      "key": "9556_CR7",
      "unstructured": "Li FP, Fraumeni JF Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747–752",
      "volume": "71",
      "year": "1969"
    },
    {
      "DOI": "10.1136/jmg.2008.058958",
      "author": "KD Gonzalez",
      "doi-asserted-by": "crossref",
      "first-page": "689",
      "journal-title": "J Med Genet",
      "key": "9556_CR8",
      "unstructured": "Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS (2009) High frequency of de novo mutations in Li-Fraumeni syndrome. J Med Genet 46:689–693",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0140-6736(03)12856-5",
      "author": "Lalloo F, Varley J, Ellis D, Moran A, O’Dair L, Pharoah P, Evans DG; Early Onset Breast Cancer Study Group",
      "doi-asserted-by": "crossref",
      "first-page": "1101",
      "journal-title": "Lancet",
      "key": "9556_CR9",
      "unstructured": "Lalloo F, Varley J, Ellis D, Moran A, O’Dair L, Pharoah P, Evans DG; Early Onset Breast Cancer Study Group (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101–1102",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10689-009-9287-z",
      "author": "OM Ginsburg",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "journal-title": "Fam Cancer",
      "key": "9556_CR10",
      "unstructured": "Ginsburg OM, Akbari MR, Aziz Z, Young R, Lynch H, Ghadirian P, Robidoux A, Londono J, Vasquez G, Gomes M, Costa MM, Dimitrakakis C, Gutierrez G, Pilarski R, Royer R, Narod SA (2009) The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. Fam Cancer 8:563–567",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMra012284",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "2339",
      "journal-title": "N Engl J Med",
      "key": "9556_CR11",
      "unstructured": "Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339–2347",
      "volume": "348",
      "year": "2003"
    },
    {
      "author": "A Meindl",
      "first-page": "323",
      "journal-title": "Dtsch Arztebl Int",
      "key": "9556_CR12",
      "unstructured": "Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK (2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 108:323–330",
      "volume": "108",
      "year": "2011"
    },
    {
      "author": "RA Eeles",
      "first-page": "101",
      "journal-title": "Cancer Surv",
      "key": "9556_CR13",
      "unstructured": "Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:101–124",
      "volume": "25",
      "year": "1995"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7967",
      "author": "J Tinat",
      "doi-asserted-by": "crossref",
      "first-page": "e108",
      "journal-title": "J Clin Oncol",
      "key": "9556_CR14",
      "unstructured": "Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bonaïti-Pellié C, Stoppa-Lyonnet D, Frébourg T (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27:e108–e109",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-1907",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "9742",
      "journal-title": "Cancer Res",
      "key": "9556_CR15",
      "unstructured": "Antoniou AC, Beesley J, McGuffog L et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70:9742–9754",
      "volume": "70",
      "year": "2010"
    }
  ],
  "reference-count": 15,
  "references-count": 15,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-012-9556-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways"
  ],
  "type": "journal-article",
  "volume": "11"
}